Bold Vision.
Innovation at its best.
ProPhase Labs Inc. is a next-generation biotech, genomics and consumer products company. Our goal is to create a healthier world with bold action and the power of insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, while developing potential game changer diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action.
We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach. ProPhase Labs’ valuable subsidiaries, their synergies, and significant growth underscore our potential for long-term value.
.




.




.
OUR COMPANIES
Press Releases
See our latest innovations and breaking news
Aug 19 2025 8:00AM ET
ProPhase Labs Announces Filing of Definitive Proxy Statement and New Date for Special Meeting of Shareholders
Read MoreAug 13 2025 8:00AM ET
ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025
Read MoreAug 12 2025 8:00AM ET
ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment
Read MoreGet In Touch
We care about your questions and will be in touch usually within 24 hours
"*" indicates required fields